Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | CellCept |
| Active Ingredient: | Mycophenolate mofetil 200mg/mL |
| Dosage Form: | Powder for oral suspension |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturer: | Patheon Inc, Mississauga, Canada |
| Product: | CellCept |
| Active Ingredient: | Mycophenolate mofetil 250mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturer: | Delpharm Milano S.r.L, Milan, Italy |
| Product: | CellCept |
| Active Ingredient: | Mycophenolate mofetil 500mg |
| Dosage Form: | Powder for infusion |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Roche Diagnostics GmbH, Mannheim, Germany Pierre Fabre Medicament Production, Idron, France |
| Product: | CellCept |
| Active Ingredient: | Mycophenolate mofetil 500mg |
| Dosage Form: | Tablet |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Recipharm Leganes S.L.U., Leganes, Spain Delpharm Milano S.r.L, Milan, Italy |
Dated this 17th day of January 2020.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).